help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 3, 2009
Endocrinology, doi:10.1210/en.2009-0539
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Waite, E.
Right arrow Articles by Le Tissier, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waite, E.
Right arrow Articles by Le Tissier, P.

Submitted on May 12, 2009
Accepted on September 22, 2009

Different Degrees of Somatotroph Ablation Compromise Pituitary Growth Hormone Cell Network Structure and Other Pituitary Endocrine Cell Types

Eleanor Waite, Chrystel Lafont, Danielle Carmignac, Norbert Chauvet, Nathalie Coutry, Helen Christian, Iain Robinson, Patrice Mollard, and Paul Le Tissier*

Division of Molecular Neuroendocrinology, National Institute for Medical Research (E.W., D.C., I.R., P.L.T.), The Ridgeway, London NW7 1AA, United Kingdom; Department of Endocrinology (C.L., N.Ch., N.Co., P.M.), Institute of Functional Genomics, Montpellier 34094, France; and Department of Physiology, Anatomy, and Genetics (H.C.), University of Oxford, Oxford OX1 3QX, United Kingdom

* To whom correspondence should be addressed. E-mail: pletiss{at}nimr.mrc.ac.uk.

We have generated transgenic mice with somatotroph-specific expression of a modified influenza virus ion channel, H37AM2, leading to ablation of GH cells with three levels of severity, dependent on transgene copy number. GH-M2low mice grow normally and have normal-size pituitaries but 40–50% reduction in pituitary GH content in adult animals. GH-M2med mice have male-specific transient growth retardation and a reduction in pituitary GH content by 75% at 42 d and 97% by 100 d. GH-M2high mice are severely dwarfed with undetectable pituitary GH. The GH secretory response of GH-M2low and GH-M2med mice to GH-releasing peptide-6 and GHRH was markedly attenuated. The content of other pituitary hormones was affected depending on transgene copy number: no effect in GH-M2low mice, prolactin and TSH reduced in GH-M2med mice, and all hormones reduced in GH-M2high mice. The effect on non-GH hormone content was associated with increased macrophage invasion of the pituitary. Somatotroph ablation affected GH cell network organization with limited disruption in GH-M2low mice but more severe disruption in GH-M2med mice. The remaining somatotrophs formed tight clusters after puberty, which contrasts with GHRH-M2 mice with a secondary reduction in somatotrophs that do not form clusters. A reduction in pituitary {beta}-catenin staining was correlated with GH-M2 transgene copy number, suggesting M2 expression has an effect on cell-cell communication in somatotrophs and other pituitary cell types. GH-M2 transgenic mice demonstrate that differing degrees of somatotroph ablation lead to correlated secondary effects on cell populations and cellular network organization.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society